Aurobindo Pharma wins key FDA nod for $138M US cough drug market entry
The drug is designed to provide temporary relief from cough caused by throat and bronchial irritation
The drug is designed to provide temporary relief from cough caused by throat and bronchial irritation
ENFLONSIA is a long-acting monoclonal antibody designed to shield infants through a typical five-month RSV season with a single, fixed dose
Experts highlighted that robust pharmacopoeial frameworks are essential for maintaining the quality, safety and efficacy of medicines
Dr Shivkumar Kalyanaraman emphasizes need for quality research, partnerships, and measurable outcomes
Consensus calls for nationwide adoption of potassium-enriched salt to reduce cardiovascular disease risk
Postdoctoral fellowship aims to build skilled talent pool in biotechnology and life sciences
The investment case for health technology in India is frequently overstated in one direction and understated in another
The study evaluated asundexian (50 mg), a once-daily oral anticoagulant candidate, versus placebo—both given alongside standard antiplatelet therapy
New purpose-built AI model targets faster R&D cycles and deeper scientific insights across life sciences
Subscribe To Our Newsletter & Stay Updated